Literature DB >> 8774851

Inhibition of cathepsin B by its propeptide: use of overlapping peptides to identify a critical segment.

J R Chagas1, M Ferrer-Di Martino, F Gauthier, G Lalmanach.   

Abstract

Ten overlapping 15-mer peptides (peptidyl amides) spanning the proregion of rat cathepsin B (residues 1p-60p) were constructed to identify minimal segments having inhibitory activity towards the mature enzyme, that could be used to develop a new generation of peptide-derived inhibitors specifically targeting the active site of the corresponding proteinase. Three synthetic peptides, containing the pentapeptide Leu-Cys-Gly-Thr-Val (residues 41p-45p) in their sequence, inhibited cathepsin B with Ki values in the micromolar range. Alkylation of the thiol group of Cys-42p of peptide PB8 (36p-50p) resulted in its rapid proteolytic degradation, suggesting that this residue is essential for inhibition. The inhibition constant was slightly improved (Ki = 2 microM) using a longer peptide (26p-50p) which was completely resistant to cleavage even after a prolonged incubation. Alkylation of its cysteinyl residue also resulted in rapid cleavage of the peptide chain. Peptides derived from the rat cathepsin B prosequence also inhibited human cathepsin B with similar Ki values. Unlike rat cathepsin B, which cleaves peptide PB8 at the G47p-G48p bond after prolonged incubation, the human enzyme cleaved both PB8 and PB11 at the Lys-40p-Leu-41p bond, in agreement with the different kinetic properties of these two proteinases. New probes with improved specificity for cysteine proteinases may therefore be designed based on the sequences of their propeptides.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8774851     DOI: 10.1016/0014-5793(96)00822-8

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  5 in total

1.  Synthetic peptides derived from the prosegments of proprotein convertase 1/3 and furin are potent inhibitors of both enzymes.

Authors:  Ajoy Basak; Claude Lazure
Journal:  Biochem J       Date:  2003-07-01       Impact factor: 3.857

2.  S-Nitrosylation of cathepsin B affects autophagic flux and accumulation of protein aggregates in neurodegenerative disorders.

Authors:  Ki-Ryeong Kim; Eun-Jung Cho; Jae-Won Eom; Sang-Seok Oh; Tomohiro Nakamura; Chang-Ki Oh; Stuart A Lipton; Yang-Hee Kim
Journal:  Cell Death Differ       Date:  2022-04-24       Impact factor: 12.067

3.  Rational Design of a Humanized Antibody Inhibitor of Cathepsin B.

Authors:  Zhefu Dai; Qinqin Cheng; Yong Zhang
Journal:  Biochemistry       Date:  2020-03-31       Impact factor: 3.162

4.  ADP-ribosylation factor 1 protein regulates trypsinogen activation via organellar trafficking of procathepsin B protein and autophagic maturation in acute pancreatitis.

Authors:  Lidiya Orlichenko; Donna B Stolz; Pawan Noel; Jaideep Behari; Shiguang Liu; Vijay P Singh
Journal:  J Biol Chem       Date:  2012-05-08       Impact factor: 5.157

5.  Natively inhibited Trypanosoma brucei cathepsin B structure determined by using an X-ray laser.

Authors:  Lars Redecke; Karol Nass; Daniel P DePonte; Thomas A White; Dirk Rehders; Anton Barty; Francesco Stellato; Mengning Liang; Thomas R M Barends; Sébastien Boutet; Garth J Williams; Marc Messerschmidt; M Marvin Seibert; Andrew Aquila; David Arnlund; Sasa Bajt; Torsten Barth; Michael J Bogan; Carl Caleman; Tzu-Chiao Chao; R Bruce Doak; Holger Fleckenstein; Matthias Frank; Raimund Fromme; Lorenzo Galli; Ingo Grotjohann; Mark S Hunter; Linda C Johansson; Stephan Kassemeyer; Gergely Katona; Richard A Kirian; Rudolf Koopmann; Chris Kupitz; Lukas Lomb; Andrew V Martin; Stefan Mogk; Richard Neutze; Robert L Shoeman; Jan Steinbrener; Nicusor Timneanu; Dingjie Wang; Uwe Weierstall; Nadia A Zatsepin; John C H Spence; Petra Fromme; Ilme Schlichting; Michael Duszenko; Christian Betzel; Henry N Chapman
Journal:  Science       Date:  2012-11-29       Impact factor: 47.728

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.